Amrita Hospital in Kochi has been announced as the host venue for the Indian Myeloma Congress 2026, a major academic event focused on advances in multiple myeloma care. Scheduled to take place from January 9 to 11, 2026, the congress is expected to attract eminent global and national experts in haematology.
Recognised as one of the country’s leading forums dedicated to myeloma, the Indian Myeloma Congress will bring together 15 internationally recognised faculty members along with prominent myeloma specialists from across India. The meeting is designed as a collaborative learning platform for clinicians, researchers, fellows, nursing professionals, and multidisciplinary haematology teams.
The scientific programme will highlight the latest developments and research across key areas of myeloma management. Topics will span early and advanced diagnosis, risk assessment, emerging treatment options, immunotherapies, transplantation strategies, minimal residual disease (MRD) assessment, supportive care, and long-term survivorship. A strong focus will be placed on translating research breakthroughs into real-world clinical practice.
Participants can expect a comprehensive academic experience featuring expert lectures, panel interactions, case-based clinical discussions, and ample opportunities for professional networking. The congress aims to contribute significantly to improving standards of myeloma care nationwide while influencing future treatment approaches in India.
(Photo courtesy: facebook/AmritaHospitalKochi)